Connection

Mark George to Double-Blind Method

Back to Details
This is a "connection" page, showing publications Mark George has written about Double-Blind Method.
Mark George
Connection Strength
1.735
Double-Blind Method
  1. Sonication of the anterior thalamus with MRI-Guided transcranial focused ultrasound (tFUS) alters pain thresholds in healthy adults: A double-blind, sham-controlled study. Brain Stimul. 2020 Nov - Dec; 13(6):1805-1812.
    View in: PubMed
    Score: 0.137
  2. Two weeks of image-guided left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation improves smoking cessation: A double-blind, sham-controlled, randomized clinical trial. Brain Stimul. 2020 Sep - Oct; 13(5):1271-1279.
    View in: PubMed
    Score: 0.134
  3. Exposure Therapy and Simultaneous Repetitive Transcranial Magnetic Stimulation: A Controlled Pilot Trial for the Treatment of Posttraumatic Stress Disorder. J ECT. 2019 Mar; 35(1):53-60.
    View in: PubMed
    Score: 0.122
  4. Prefrontal versus motor cortex transcranial direct current stimulation (tDCS) effects on post-surgical opioid use. Brain Stimul. 2017 Nov - Dec; 10(6):1096-1101.
    View in: PubMed
    Score: 0.110
  5. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimul. 2015 Jul-Aug; 8(4):787-94.
    View in: PubMed
    Score: 0.094
  6. Fast left prefrontal rTMS reduces post-gastric bypass surgery pain: findings from a large-scale, double-blind, sham-controlled clinical trial. Brain Stimul. 2014 Jan-Feb; 7(1):42-8.
    View in: PubMed
    Score: 0.086
  7. The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial. Brain Stimul. 2013 Nov; 6(6):925-8.
    View in: PubMed
    Score: 0.082
  8. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue craving. Biol Psychiatry. 2013 Apr 15; 73(8):714-20.
    View in: PubMed
    Score: 0.081
  9. Naloxone-reversible modulation of pain circuitry by left prefrontal rTMS. Neuropsychopharmacology. 2013 Jun; 38(7):1189-97.
    View in: PubMed
    Score: 0.080
  10. Using interleaved transcranial magnetic stimulation/functional magnetic resonance imaging (fMRI) and dynamic causal modeling to understand the discrete circuit specific changes of medications: lamotrigine and valproic acid changes in motor or prefrontal effective connectivity. Psychiatry Res. 2011 Nov 30; 194(2):141-8.
    View in: PubMed
    Score: 0.073
  11. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010 May; 67(5):507-16.
    View in: PubMed
    Score: 0.066
  12. Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS). Brain Stimul. 2009 Apr; 2(2):88-92.
    View in: PubMed
    Score: 0.062
  13. Prefrontal EEG asymmetry as a potential biomarker of antidepressant treatment response with transcranial magnetic stimulation (TMS): a case series. Clin EEG Neurosci. 2008 Jul; 39(3):125-30.
    View in: PubMed
    Score: 0.058
  14. A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. Schizophr Res. 2007 Aug; 94(1-3):332-41.
    View in: PubMed
    Score: 0.055
  15. A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. Schizophr Res. 2007 Jul; 93(1-3):42-50.
    View in: PubMed
    Score: 0.054
  16. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology. 2007 Aug; 32(8):1649-60.
    View in: PubMed
    Score: 0.053
  17. Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology. 2004 Jul; 29(7):1395-407.
    View in: PubMed
    Score: 0.044
  18. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003 Feb; 5(1):40-7.
    View in: PubMed
    Score: 0.040
  19. Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial. Biol Psychiatry. 2021 11 15; 90(10):721-728.
    View in: PubMed
    Score: 0.036
  20. Transcranial Direct Current Stimulation vs Sham Stimulation to Treat Aphasia After Stroke: A Randomized Clinical Trial. JAMA Neurol. 2018 12 01; 75(12):1470-1476.
    View in: PubMed
    Score: 0.030
  21. Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans: A Randomized Clinical Trial. JAMA Psychiatry. 2018 09 01; 75(9):884-893.
    View in: PubMed
    Score: 0.030
  22. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry. 1997 Dec; 154(12):1752-6.
    View in: PubMed
    Score: 0.028
  23. Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. Am J Drug Alcohol Abuse. 2018; 44(1):47-55.
    View in: PubMed
    Score: 0.028
  24. 61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial. Brain Stimul. 2017 Jul - Aug; 10(4):847-849.
    View in: PubMed
    Score: 0.027
  25. Motor/Prefrontal Transcranial Direct Current Stimulation (tDCS) Following Lumbar Surgery Reduces Postoperative Analgesia Use. Spine (Phila Pa 1976). 2016 May; 41(10):835-9.
    View in: PubMed
    Score: 0.025
  26. Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury. Neuropsychopharmacology. 2016 Apr; 41(5):1191-8.
    View in: PubMed
    Score: 0.024
  27. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depress Anxiety. 2012 Oct; 29(10):883-90.
    View in: PubMed
    Score: 0.019
  28. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007 Dec 01; 62(11):1208-16.
    View in: PubMed
    Score: 0.014
  29. Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res. 2006 Mar 31; 146(2):179-84.
    View in: PubMed
    Score: 0.012
  30. A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett. 2005 Mar 16; 376(3):177-81.
    View in: PubMed
    Score: 0.011
  31. Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study. Neurocase. 2003 Jun; 9(3):274-82.
    View in: PubMed
    Score: 0.010
  32. Low CSF somatostatin associated with response to nimodipine in patents with affective illness. Biol Psychiatry. 2003 Jan 15; 53(2):180-3.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.